Atossa Genetics, Inc. (NASDAQ: ATOS)
Atossa Genetics is focused on preventing breast cancer through the commercialization of patented, FDA-designated Class II diagnostic medical devices and, through its wholly-owned subsidiary, The National Reference Laboratory for Breast Health, Inc. ("NRLBH"), patented, laboratory developed tests (LDT) that can detect precursors to breast cancer up to eight years before mammography.
Company Website: http://www.atossagenetics.com/
Atossa Genetics, Inc. (NASDAQ: ATOS) Stock Message Board
3 | $ATOS t | PoemStone | 07/15/2014 11:31:48 AM |
2 | Latest Atossa Genetics Inc (ATOS) Headlines | Stock_Tracker | 03/13/2014 5:35:18 AM |
1 | ATOS Stock Charts Last: -0.0099 Thursday, | chartguy89 | 02/27/2014 2:13:04 PM |